Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
Published . Updated .
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
Directly affected
- No company is named in this report.
Indirectly affected
- CPHI CHINA PHARMA HLDGS INC
GA selected CPHI as a RELATED security because its canonical security name directly matches this event's themes: pharma, china. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
China Pharma Holdings (CPHI) since this story, compared with the market
Since the first closing price after “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion,” China Pharma Holdings (CPHI) is +2.49%. The S&P 500 fund (SPY) is -1.08% over the same days, a +3.57% difference versus the market.
Disclosure records for China Pharma Holdings (CPHI) within two months of 2 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around China Pharma Holdings (CPHI)
Companies mentioned with this story
- CPHI China Pharma Holdings
China Pharma Holdings (CPHI) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion.” Reason on file: GA selected CPHI as a RELATED security because its canonical security name directly matches this event's themes: pharma, china. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
China Pharma Holdings (CPHI)
China Pharma Holdings (CPHI) is the company in “Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion,” the 2 Oct 2026 this story story.
What ties China Pharma Holdings (CPHI) to the headline is this: GA selected CPHI as a RELATED security because its canonical security name directly matches this event's themes: pharma, china. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Acadia Healthcare (ACHC) is here too. Its reason reads: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the China Pharma Holdings (CPHI) price range
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. CPHI traded between 0.64 and 1.28 across 20 sessions. The latest close on file is 0.67.
What the saved facts support for China Pharma Holdings (CPHI)
100 out of 100
“Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion” scores 100 out of 100. The score uses 6 linked companies.